Triptorelin Research & Studies
We track 20 published, PubMed-indexed studies for Triptorelin, spanning 1993 to 2025. The research below includes 11 reviews, 7 clinical trials, 1 research article, 1 meta-analysis.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
11
Reviews
7
Clinical Trials
1
Research Article
1
Meta-Analysis
Triptorelin: The Need for Legal Protection Aimed at the Full Political and Social Integration of Gender Variant youth. A Comparison of Different Global realities.
ReviewLacasella G, Volonnino G, et al.|Clin Ter|2025
Adolescent Gender Dysphoria in Italy: Reflections on Triptorelin, Consent, and Care.
ReviewLippi M, Orsini F, et al.|Clin Ter|2025
A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty.
Clinical TrialYu X, Cheng X, et al.|Adv Ther|2024
Triptorelin nanoparticle-loaded microneedles for use in assisted reproductive technology.
Research ArticleLu X, Sun Y, et al.|Drug Deliv|2023
Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.
Clinical TrialLi X, Li H, et al.|Adv Ther|2022
Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.
ReviewBertelloni S, Mucaria C, et al.|Expert Rev Clin Pharmacol|2018
Three cases of transient hyperthyroidism after triptorelin treatment - case report and literature review.
ReviewMiao J, Yan Q, et al.|Gynecol Endocrinol|2018
Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation .
Meta-AnalysisDurand A, Tauber M, et al.|Horm Res Paediatr|2017
Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.
ReviewFrampton JE|Drugs|2017
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer.
ReviewMerseburger AS, Hupe MC|Adv Ther|2016
Triptorelin for the treatment of endometriosis.
ReviewLeone Roberti Maggiore U, Scala C, et al.|Expert Opin Pharmacother|2014
Triptorelin in the management of prostate cancer.
ReviewPloussard G, Mongiat-Artus P|Future Oncol|2013
Triptorelin embonate (6-month formulation).
ReviewKeating GM|Drugs|2010
Triptorelin embonate: a 6-month formulation for prostate cancer.
ReviewWhelan P|Expert Opin Pharmacother|2010
Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.
Clinical TrialLundström EA, Rencken RK, et al.|Clin Drug Investig|2009
A crossover study of triptorelin and leuprorelin acetate.
Clinical TrialCheung TK, Lo KW, et al.|Fertil Steril|2000
Effects of triptorelin versus placebo on the symptoms of endometriosis.
Clinical TrialBergqvist A, Bergh T, et al.|Fertil Steril|1998
Triptorelin acetate administration in early pregnancy: case reports and review of the literature.
ReviewChardonnens D, Sylvan K, et al.|Eur J Obstet Gynecol Reprod Biol|1998
Long-acting triptorelin for the treatment of endometriosis.
Clinical TrialChoktanasiri W, Boonkasemsanti W, et al.|Int J Gynaecol Obstet|1996
Endometriosis.
Clinical TrialDevogelaer JP, Nagant de Deuxchaisnes C, Donnez J|Lancet|1993